Actuate Therapeutics, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Actuate Therapeutics, Inc. (ACTU) reported Adjustments to Additional Paid in Capital, Warrant Issued of $0 for the 3-month period ending 2023-06-30, per its 10-Q filed 2024-09-24.
Discontinued
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2024-09-24
- Actuate Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-06-30 was $0.00.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month |
|---|---|
| 2023-06-30 | $0.00 10-Q · filed 2024-09-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B |